Phosphodiesterase type 5 inhibition improves early memory consolidation of object information
- PMID: 15312986
- DOI: 10.1016/j.neuint.2004.03.022
Phosphodiesterase type 5 inhibition improves early memory consolidation of object information
Abstract
The nitric oxide (NO)-cyclic GMP (cGMP) signaling pathway is assumed to play an important role in processes underlying learning and memory. We used phosphodiesterase type 5 (PDE5) inhibitors to study the role of cGMP in object- and spatial memory. Our results and those reported in other studies indicate that elevated hippocampal cGMP levels are required to improve the memory performance of rodents in object recognition and passive avoidance learning, but not in spatial learning. The timing of treatment modulates the effects on memory and strongly supports a role for cGMP in early stages of memory formation. Alternative explanations for the improved memory performance of PDE5 inhibitors are also discussed. Immunocytochemical studies showed that in vitro slice incubations with PDE5 inhibitors increase NO-stimulated cGMP levels mainly in hippocampal varicose fibers. Reviewing the available data on the localization of the different components of the NO-cGMP signaling pathway, indicates a complex interaction between NO and cGMP, which may be independent of each other. It is discussed that further studies are needed, immunocytochemical and behavioral, to better understand the cGMP-mediated molecular mechanisms underlying memory formation.
Similar articles
-
The selective PDE5 inhibitor, sildenafil, improves object memory in Swiss mice and increases cGMP levels in hippocampal slices.Behav Brain Res. 2005 Oct 14;164(1):11-6. doi: 10.1016/j.bbr.2005.04.021. Behav Brain Res. 2005. PMID: 16076505
-
Time-dependent involvement of cAMP and cGMP in consolidation of object memory: studies using selective phosphodiesterase type 2, 4 and 5 inhibitors.Eur J Pharmacol. 2007 Mar 8;558(1-3):107-12. doi: 10.1016/j.ejphar.2006.11.041. Epub 2006 Dec 1. Eur J Pharmacol. 2007. PMID: 17207788
-
The role of phosphodiesterase isoforms 2, 5, and 9 in the regulation of NO-dependent and NO-independent cGMP production in the rat cervical spinal cord.J Chem Neuroanat. 2006 Jun;31(4):275-303. doi: 10.1016/j.jchemneu.2006.02.006. Epub 2006 Apr 18. J Chem Neuroanat. 2006. PMID: 16621445
-
Pulmonary hypertension: inhaled nitric oxide, sildenafil and natriuretic peptides.Curr Opin Pharmacol. 2005 Jun;5(3):245-50. doi: 10.1016/j.coph.2004.12.008. Curr Opin Pharmacol. 2005. PMID: 15907910 Review.
-
Phosphodiesterase 5 mechanisms and therapeutic applications.Am J Cardiol. 2005 Dec 26;96(12B):29M-31M. doi: 10.1016/j.amjcard.2005.07.008. Epub 2005 Jul 21. Am J Cardiol. 2005. PMID: 16387563 Review.
Cited by
-
The PDE5 inhibitor vardenafil does not affect auditory sensory gating in rats and humans.Psychopharmacology (Berl). 2013 Jan;225(2):303-12. doi: 10.1007/s00213-012-2817-7. Epub 2012 Aug 2. Psychopharmacology (Berl). 2013. PMID: 22855271 Clinical Trial.
-
Phosphodiesterase inhibition by sildenafil citrate attenuates a maze learning impairment in rats induced by nitric oxide synthase inhibition.Psychopharmacology (Berl). 2006 Jan;183(4):439-45. doi: 10.1007/s00213-005-0232-z. Epub 2005 Nov 18. Psychopharmacology (Berl). 2006. PMID: 16320087
-
Phosphodiesterase type 5 and cancers: progress and challenges.Oncotarget. 2017 Oct 12;8(58):99179-99202. doi: 10.18632/oncotarget.21837. eCollection 2017 Nov 17. Oncotarget. 2017. PMID: 29228762 Free PMC article. Review.
-
Sildenafil promotes dual memory effects in young rats: involvement of dopamine reuptake.Psychopharmacology (Berl). 2025 May 19. doi: 10.1007/s00213-025-06806-x. Online ahead of print. Psychopharmacology (Berl). 2025. PMID: 40383851
-
cGMP-dependent protein kinase I, the circadian clock, sleep and learning.Commun Integr Biol. 2009 Jul;2(4):298-301. doi: 10.4161/cib.2.4.8220. Commun Integr Biol. 2009. PMID: 19721870 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical